Quick Answer
Arteris, Inc. reported Cash And Cash Equivalents At Carrying Value of $33.90 million for the year ending 2025.
- Arteris, Inc. showed an increase of +147.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Arteris, Inc.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $11.24 million | Q1 2022: $82.24 million | Q2 2022: $81.30 million | Q3 2022: $68.20 million | Q1 2023: $28.51 million | Q2 2023: $26.33 million | Q3 2023: $18.63 million | Q1 2024: $26.12 million | Q2 2024: $22.13 million | Q3 2024: $17.83 million | Q1 2025: $16.37 million | Q2 2025: $16.10 million | Q3 2025: $17.42 million.
- Over the full 6 years of available data (2020 to 2025), Arteris, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 188.7%.
- Historical annual values: Fiscal year 2025: $33.90 million | Fiscal year 2024: $13.68 million | Fiscal year 2023: $13.70 million | Fiscal year 2022: $37.42 million | Fiscal year 2021: $85.83 million | Fiscal year 2020: $11.74 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: